Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

Shaoli Song

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2544-7522; OpenAlex author ID A5087860365. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
14
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: 2 papers · 2024: none · 2025: none · 2026: 3 papers

Papers 7

  1. A pilot study of nectin-4-targeted radioligand [68Ga]Ga-FZNR-1 in patients with pancreatic ductal adenocarcinoma: head-to-head comparison with [18F]-FDG. Last author DOI 10.1007/s00259-025-07609-0↗
  2. Translation of a novel EphA2-targeted PET tracer from preclinical models to first-in-human studies in pancreatic cancer. Last author DOI 10.1007/s00259-026-07966-4↗
  3. AI-guided design of plectin-1-targeted 68Ga-radiotracers reveals EP300-mediated membrane relocalization of plectin-1 in pancreatic ductal adenocarcinoma. Last author DOI 10.1186/s12951-026-04938-6↗
  4. The added value of [68Ga]Ga-DOTA-FAPI-04 PET/CT in pancreatic cancer: a comparison to [18F]F-FDG. Last author DOI 10.1007/s00330-023-09445-y↗
  5. Preoperative prediction of microvascular invasion and perineural invasion in pancreatic ductal adenocarcinoma with 18F-FDG PET/CT radiomics analysis. Last author DOI 10.1016/j.crad.2023.05.007↗
  6. Fibroblast activation protein-based theranostics in pancreatic cancer. Co-author DOI 10.3389/fonc.2022.969731↗
  7. A Novel Validated Recurrence Stratification System Based on 18F-FDG PET/CT Radiomics to Guide Surveillance After Resection of Pancreatic Cancer. Co-author DOI 10.3389/fonc.2021.650266↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xianjun Yu · 3 shared papers, 2021–2026 · strength 0.61
  2. Chunjuan Jiang · 2 shared papers, 2026 · strength 0.59
  3. Miaoyan Wei · 2 shared papers, 2021–2026 · strength 0.43
  4. Si Shi · 2 shared papers, 2021–2023 · strength 0.32
  5. Xinyu Liu · 1 shared paper, 2026 · strength 0.29
  6. Zhen Chen · 1 shared paper, 2022 · strength 0.20
  7. Peiwen Yang · 1 shared paper, 2022 · strength 0.20
  8. Chien‐shan Cheng · 1 shared paper, 2022 · strength 0.20
  9. Chun Ling Jiang · 1 shared paper, 2023 · strength 0.19
  10. Qiufang Liu · 1 shared paper, 2023 · strength 0.18
  11. Shuai Liu · 1 shared paper, 2023 · strength 0.18
  12. Bo Zhang · 1 shared paper, 2021 · strength 0.14
  13. Wei Wang · 1 shared paper, 2021 · strength 0.14
  14. Jin Xu · 1 shared paper, 2021 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.